<DOC>
	<DOCNO>NCT01506258</DOCNO>
	<brief_summary>The purpose study determine whether plasticity autologous intravenous application cord blood stem cell would improve clinical course asphyxiate newborn .</brief_summary>
	<brief_title>Autologous Stem Cells Newborns With Oxygen Deprivation</brief_title>
	<detailed_description>When oxygen deprivation , frequently premature newborn , brain organ suffer severe consequence . There evidence hematopoietic stem cell help scenario promote release growth-enhancing factor help control damage due `` homing '' capacity , attract injured site . Cord placental blood high concentration stem cell , obtention relatively easy , seem like feasible treatment perinatal hypoxia . There current clinical trial use cryopreserved cord blood patient , , stem cell frozen thaw infused , lose considerable amount stem cell ( almost half ) . We want evaluate condition infuse non-cryopreserved autologous cord placental blood believe beneficial due great amount cell infuse , avoidance cryoprotection agentÂ´s toxicity low cost .</detailed_description>
	<mesh_term>Anoxia</mesh_term>
	<mesh_term>Acidosis</mesh_term>
	<mesh_term>Multiple Organ Failure</mesh_term>
	<mesh_term>Hypoxia , Brain</mesh_term>
	<criteria>Apgar &lt; 5 5 minute Mixed metabolic acidosis pH &lt; 7.0 umbilical cord blood sample Neurological manifestation compatible HypoxicIschemic Encephalopathy Any degree organic/systemic affectation ( cardiovascular , gastrointestinal , hematologic and/or respiratory ) Neurodegenerative , autoimmune genetic disease Active infection birth Informed Consent sign</criteria>
	<gender>All</gender>
	<minimum_age>37 Weeks</minimum_age>
	<maximum_age>42 Weeks</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>CD34+</keyword>
	<keyword>perinatal hypoxia</keyword>
	<keyword>autologous hematopoietic stem cell</keyword>
	<keyword>cord placental blood</keyword>
	<keyword>cerebral palsy</keyword>
</DOC>